Why Your Waistline Tells More About Your Body Composition Than BMI- Ways To Trim Down Fat

Updated Jan 16, 2025 | 04:30 PM IST

SummaryA global commission of 56 medical experts is calling for redefining obesity, emphasizing more comprehensive methods than BMI, potentially transforming how over a billion people worldwide are diagnosed and treated for obesity.
Why Your Waistline Tells More About Your Body Composition Than Your BMI

BMI has been the benchmark in evaluating health and fitness for many years. The formula is quite simple: weight in kilograms divided by the square of height in meters. This would easily tell if one is underweight, within the healthy weight range, overweight, or obese. But with new research findings, scientists are now questioning its accuracy and usefulness as a total measure of body composition.

The report, published in The Lancet Diabetes & Endocrinology, has sparked a global conversation on rethinking BMI. Supported by more than 50 international medical experts, the report suggests classifying obesity into "clinical" and "pre-clinical" types for better diagnosis and treatment. The shift underscores a growing consensus: BMI alone may not tell the full story of your health.

While BMI is simple to calculate and universally accessible, it is far from perfect. It does not consider muscle mass, bone density, or fat distribution, leading to misleading conclusions in some cases. For example, athletes with a high muscle mass may be considered overweight, whereas individuals with normal BMI might carry unhealthy amounts of visceral fat.

A landmark study in JAMA Network Open studied more than 155,000 postmenopausal women and found that women with a normal BMI but a waist size over 35 inches were more likely to die from heart disease or cancer compared with their counterparts whose waists are smaller. That makes a great case for how BMI can be insufficient and fat distribution must be factored into account.

Not all body fat is equal. Subcutaneous fat, which lies just beneath the skin, is relatively harmless. The real health danger lies in visceral fat—fat that surrounds internal organs. Unlike subcutaneous fat, visceral fat is metabolically active, releasing stress hormones like cortisol and inflammatory substances that raise blood pressure, blood sugar, and cholesterol levels. These effects significantly increase the risk of conditions such as heart disease, type 2 diabetes, and certain cancers.

BMI Isn't Always the Best Measure of Body Composition — Here's What to Use Instead

Since BMI is not the most reliable measure, scientists and doctors have sought other means to measure body composition more accurately.

1. Waist Circumference

A simple tape measure can provide valuable insight into your health. Measure your waist at the level of your belly button, ensuring the tape is parallel to the ground. For women, a waist measurement under 35 inches is considered healthy, while for men, the goal is under 40 inches.

2. Waist-to-Hip Ratio

This is the ratio of your waist circumference to that of your hips. To calculate it, divide your waist measurement by your hip measurement. According to the National Center for Biotechnology Information, a ratio under 0.8 for women and 0.9 for men is considered healthy.

3. Body Roundness Index (BRI)

A newer method that seems to be receiving more attention involves the Body Roundness Index or BRI: height, weight, and girth are placed together to represent a more advanced view of what body composition says. Research presented in JAMA Network Open offers evidence that this BRI predicts mortality risk greater than BMI in some cases- a promising weapon for public health.

Also Read: Using BMI To Classify People As Obese Is Flawed Say Experts

Ways To Cut Off Unhealthy Fat

The good news is that visceral fat responds well to lifestyle changes. Here are three evidence-based strategies:

Time-Restricted Eating

Adopting an eating window of 12 hours—such as from 7 a.m. to 7 p.m.—can significantly reduce visceral fat, according to a study published in Nutrition Research Reviews. This approach not only helps control caloric intake but also reduces late-night snacking, a known risk factor for abdominal obesity.

Limit Alcohol Intake

Excessive alcohol consumption is associated with increased belly fat. A 2017 study published in Public Health Nutrition revealed that alcohol increases the levels of insulin and encourages the storage of fat in the abdominal area. Limiting alcohol to occasional indulgence helps avoid weight gain in this region.

High-Intensity Interval Training (HIIT)

HIIT involves repeated episodes of high-intensity exercise separated by periods of rest. A review in *Sports Medicine* concluded that HIIT is very effective in reducing visceral and total body fat. It can be noted that adding just 20 minutes of HIIT two times a week can make all the difference.

The reliance on BMI as a sole indicator of health is increasingly being challenged. While it remains a convenient screening tool, its limitations necessitate a broader approach that considers factors like fat distribution, waist circumference, and new metrics such as BRI.

In the simplest of words, health is multi-dimensional, and shifting perspectives from considering weight solely to broader measures of body composition will get people a much clearer understanding of where their health risks are so that they can take the action required for a better quality of life. Through adjustment to diet, exercise, or perhaps through innovative metrics like BRI, health is well within reach of the individual.

This dynamic conversation raises the point about personalized health screenings, which helps everyone get more relevant tools fitting their unique lives and circumstances. As body composition research is enhanced, so do the futures look brighter and brighter for the times of measurement when it comes to health.

Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology.

Association of Normal-Weight Central Obesity With All-Cause and Cause-Specific Mortality Among Postmenopausal Women. JAMA Netw Open. 2019

Waist-Hip Ratio. NIH.

Physiological responses to food intake throughout the day. Nutr Res Rev. 2014

Association between abdominal obesity and alcohol drinking pattern in normal-weight, middle-aged adults. Public Health Nutr. 2017

End of Article

US Woman Runs 7 Marathons While Pregnant: How Can It Affect Mother And Baby?

Updated Nov 20, 2026 | 08:00 PM IST

Summary38-year-old Deirdre Keane completed seven World Marathon Majors while pregnant, including the New York City Marathon at 34 weeks. After receiving medical clearance, she continued running while monitoring her health. Marathon running may not be safe for all pregnant women. Medical clearance and individual assessment remain essential.
US Woman Runs 7 Marathons While Pregnant: How Can It Affect Mother And Baby?

Credit: AP Photos

A 38-year-old US nurse practitioner has completed seven marathons while pregnant with her first child, raising questions about the safety of intense exercise during pregnancy.

Deirdre Keane, who works at Memorial Sloan Kettering Cancer Center, had completed more than 60 marathons before taking on the World Marathon Majors.

She discovered she was pregnant after noticing a slower pace during the Tokyo Marathon in March. After receiving clearance from her obstetrician-gynaecologist (OB-GYN), she decided to continue racing.

US Woman Completes Seven Marathons While Pregnant

The World Marathon Majors include races in Tokyo, Boston, London, Sydney, Berlin, Chicago and New York.

Keane had initially signed up for 11 events, including seven major marathons, a trail marathon, two ultramarathons and an Ironman competition.

After discovering her pregnancy, she dropped the Ironman and one ultramarathon and agreed to take the Ireland marathon slowly.

She completed the New York City Marathon in just over four hours at 34 weeks of pregnancy, averaging 9 minutes and 26 seconds per mile, according to New York Road Runners. She had finished the same race in just over three hours in 2025.

"I knew how bizarre it was to be running a marathon at 34 weeks, but I also knew how fit I was and self-aware of my body at this point," Keane told The Associated Press.

Her doctor advised her to monitor her nutrition and hydration and stop exercising at the first sign of muscle cramping, according to the World Running Network.

"I want to teach my son resilience and that he can do hard things," she said.

Is It Safe To Run Marathons During Pregnancy?

Exercise is generally safe during an uncomplicated pregnancy. However, the intensity and type of activity matter.According to the American College of Obstetricians and Gynecologists (ACOG), women with healthy pregnancies can continue or begin regular physical activity after consulting their OB-GYN.

Women who regularly performed vigorous aerobic exercise before pregnancy may also be able to continue with medical approval.

However, research on prolonged, high-intensity activities such as marathon running during pregnancy remains limited.

ACOG recommends at least 150 minutes of moderate-intensity aerobic activity every week for pregnant women without medical or obstetric complications. Brisk walking and gardening are examples.

How Can Exercise Benefit The Mother And Baby?

Regular physical activity during pregnancy can:

  • Reduce back pain and constipation.
  • Lower the risk of gestational diabetes and preeclampsia.
  • Reduce the likelihood of a cesarean birth.

However, these benefits do not mean strenuous exercise is suitable for every pregnant woman. Consult an OB-GYN before starting or continuing an intense workout routine.

What Precautions Should Pregnant Women Take?

ACOG recommends the following precautions:

  • Stay hydrated: Drink water before, during, and after exercise. Dizziness, a racing heartbeat and dark yellow urine can indicate dehydration.
  • Avoid overheating: Wear loose-fitting clothes and exercise in a cool environment. Avoid workouts in extreme heat or humidity.
  • Use adequate support: Wear a supportive sports bra. A belly support belt may help later in pregnancy.
  • Avoid certain positions: Limit lying flat on your back or standing motionless for prolonged periods, as these can affect circulation and blood pressure.

Which Activities Should Pregnant Women Avoid?

Pregnant women should avoid activities that increase the risk of falls, abdominal injuries or overheating, including:

  • Contact sports such as boxing, ice hockey, soccer and basketball.
  • Horseback riding, downhill skiing, surfing and off-road cycling.
  • Skydiving and scuba diving.
  • Hot yoga and hot Pilates.
  • Exercising above 6,000 feet if they do not already live at high altitude.

Warning Signs To Watch Out For During Exercise

ACOG advises pregnant women to stop exercising and contact their OB-GYN if they experience:

  • Vaginal bleeding.
  • Dizziness or fainting.
  • Shortness of breath before exercising.
  • Chest pain or headache.
  • Muscle weakness.
  • Calf pain or swelling.
  • Regular, painful uterine contractions.
  • Fluid leaking or gushing from the vagina.

End of Article

How Keep The Weight Off After GLP-1 Treatment: Lancet Study Compares 5 Weight Maintenance Strategies

Updated Nov 16, 2026 | 08:00 PM IST

SummaryA recent study published in The Lancet's eClinicalMedicine compared five weight loss maintenance strategies after stopping or changing original GLP-1 treatment.
How Keep The Weight Off After GLP-1 Treatment: Lancet Study Compares 5 Weight Maintenance Strategies

Credit: AI-generated image

What happens when people stop taking GLP-1 weight-loss injections like Ozempic, Wegovy or Mounjaro? Do they regain weight, switch to another medication or consider bariatric surgery?

A new study published in The Lancet's eClinicalMedicine examined that what people do after their initial GLP-1 treatment can make a significant difference in their long-term weight outcomes.

Maintaining Weight After GLP-1 Treatment

Also read: World Diabetes Day: Why Some Diabetes Patients May Not Be Suitable For GLP-1 Treatment, Experts Explain

Researchers at Cleveland Clinic examined health records from 20,486 patients who had taken semaglutide or tirzepatide injections for at least three months.

They compared five weight loss maintenance over a two-year period: continuing the original weight loss medication, switching between the two drugs, moving to another obesity medication, undergoing bariatric surgery or stopping treatment altogether without pursuing another option.

After two years, the average weight reductions were:

  • Bariatric surgery: Approximately 28% of body weight.
  • Switching between semaglutide and tirzepatide: 16%.
  • Continuing the original GLP-1 medication: Nearly 11%.
  • Switching to another obesity medication: Approximately 8%.
  • Stopping treatment without further intervention: Approximately 4%.

These results indicate that discontinuing GLP-1 treatment does not mean all the lost weight will come back. But patients who stopped treatment without another medical or surgical intervention experienced the lowest success in keeping the weight off.

The study also found that the outcomes of switching depended on which medication patients were taking initially. Those who moved from semaglutide to tirzepatide lost more weight than those who continued semaglutide. However, among people initially taking tirzepatide, remaining on the medication led to greater weight loss than switching to semaglutide.

What Happens To Blood Sugar And Blood Pressure After Stopping?

Also read: Stopping Ozempic or Wegovy May Double Your Risk Of Heart Attack, Death

Not just weight loss, the findings also covered metabolic outcomes as patients with existing health conditions also showed significant differences.

Among participants with type 2 diabetes, bariatric surgery proved to drive major improvement in HbA1c. This was followed by switching between semaglutide and tirzepatide, continuing the original medication and moving to another obesity drug.

Patients with hypertension who continued treatment also experienced greater reductions in blood pressure than those who stopped.

Those who discontinued treatment without another intervention showed the smallest improvements in blood glucose control and blood pressure.

Why Do People Stop Taking Weight-Loss Injections?

GLP-1 medications have become increasingly popular for managing diabetes and combating obesity, but long-term treatment can be difficult for some patients to maintain.

Cost, insurance and side effects are among the reasons why people may discontinue these medicines. Gastrointestinal symptoms like nausea, vomiting, diarrhoea and constipation can also affect adherence to treatment.

People who cannot continue their original medication, and are considering switching to another treatment or considering bariatric surgery should discuss their options with their healthcare providers.

Lead author Hamlet Gasoyan, a researcher at Cleveland Clinic's Center for Value-Based Care Research, said, “The encouraging news is that, for patients who need to stop their injectable GLP-1 medication, it does not mean that their obesity treatment journey has to end.”

Co-author Ali Aminian, director of Cleveland Clinic's Bariatric and Metabolic Institute, added, “When a patient stops a GLP-1 medication, the most important question is what comes next.”

He noted that patients who stopped all treatment had the least weight loss while those who moved on to another therapy, particularly bariatric surgery, did significantly better.

End of Article

Not Everyone With Obesity Is Unhealthy: New Study Challenges BMI

Updated Nov 12, 2026 | 07:17 AM IST

SummaryA recent study found that body mass index (BMI) could inaccurately diagnose people with obesity. It suggested that overweight people should be classified into two categories: pre-clinical obesity and clinical obesity.
Not Everyone With Obesity Is Unhealthy: New Study Challenges BMI

Credit: iStock

For years, body mass index (BMI) has been a key health marker to track obesity. But a recent study suggests that not everyone classified as obese based on their BMI may have obesity-related health problems. Researchers say just considering BMI alone may lead to incorrect diagnosis in some people while overlooking others with excess body fat and related health risks.

The international study, involving more than 844,000 adults across China, the UK, the US and Spain, supports a different approach that considers body fat distribution, waist measurement and the impact of excess fat on organ function.

Researchers propose distinguishing between two categories: pre-clinical obesity, in which excess body fat increases health risks but has not impaired organ function, and clinical obesity, in which excess fat is already affecting the body's ability to function.

BMI Alone Not Enough To Diagnose Obesity

Also read: Why WHO Wants To Use Smartwatches To Track Physical Activity & Sedentary Behaviour At A Population Level?

BMI is calculated by dividing a person's weight in kilograms by their height in metres squared. It is used to classify people as underweight, normal weight, overweight or obese.

However, BMI does not directly measure body fat or show where fat is distributed. It also cannot distinguish between fat and muscle mass. Consequently, two people with the same BMI may have very different body compositions and health risks.

The researchers found that adding waist circumference and waist-to-height ratio to BMI helped identify people whose excess body fat might otherwise be missed.

The analysis suggested that BMI alone missed obesity level body fat in up to 8.6% of participants, while incorrectly classifying up to 3.1% as having obesity in the study groups.

Professor Francesco Rubino, senior author of the study and Chair of Metabolic and Bariatric Surgery at King's College London, said, “Body mass index alone cannot tell us whether someone is already ill or at risk of illness, or what care they need, leaving people vulnerable to both undertreatment and overtreatment.”

Difference Between Clinical And Pre-Clinical Obesity

Also read: Loud Snoring Is Not Always Harmless: Sleep Apnoea can Become a Stroke-Risk Concern

The researchers used a framework proposed by the Lancet Diabetes and Endocrinology Commission in 2025. It separates obesity into two categories based on whether excess body fat has affected a person's health.

  • Pre-clinical obesity: A person has excess body fat that increases their risk of developing health problems, but their organ function and everyday activities remain unaffected.
  • Clinical obesity: Excess body fat has impaired organ function or affected a person's ability to perform daily activities. It is considered an active disease that requires clinical assessment.

The study estimated that only around 23% to 31% of people classified as having obesity across the four study populations had clinical obesity. This represented approximately 5.6% to 10.9% of the overall adult populations studied.

When Do People With Pre-Clinical Obesity Develop Health Problems?

The researchers followed participants over time to examine how often pre-clinical obesity progressed to clinical obesity.

They found that approximately 77% to 91% of people classified as having pre-clinical obesity did not progress to clinical obesity over 10 years. However, progression rates differed across the study populations.

Clinical obesity was linked with a higher risk of death while pre-clinical obesity had a more modest increase in risk.

Professor Rubino said, “Preclinical obesity should therefore be neither treated automatically as active disease nor dismissed as harmless. Some people may need preventive treatment, but its intensity should match their individual risk.”

The findings do not mean that people with pre-clinical obesity should ignore excess body fat. Rather, they highlight the importance of assessing individual health risks instead of making treatment decisions based on BMI alone.

People with excess body fat may still benefit from lifestyle hanges, treatment and preventive care even if they have not developed organ dysfunction.

End of Article